Results

Total Results: over 10,000 records

Showing results for "risk".

9921. Archived: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-december-2017
      December 12, 2017 - Including the posttrial phases, the WHI trial had up to 13 years of follow-up to assess how risks for … hormone therapy (relative risk [RR], 1.23 [95% CI, 1.00 to 1.52]) during a mean follow-up of 5 years … There were significant trends toward lower risks of these outcomes in younger women (50 to 59 years) … and higher risks in older women (70 to 79 years) randomized to estrogen alone relative to placebo. 13 … Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.

9922. Screening for Coronary Heart Disease: Clinician Fact Sheet (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/cAs__BR8J4rgcZ4vQgfaTx
      April 01, 2009 - A patient’s 10-year risk for CHD is determined based on age, gender, and conventional CHD risk factors … A variety of electronic or on-line risk calculators that use risk scoring algorithms derived from the … The added value of novel risk factors (e.g., CRP, homocysteine) above and beyond conventional risk … careful discussion with the patient about the risks and benefits of screening. … y If so, consider screening for this patient but only after a discussion of the risks and benefits.

9923. Psn-Pdf (pdf file)
      psnet.ahrq.gov/node/39643/psn-pdf
      December 21, 2014 - A systematic quantitative assessment of risks associated with poor communication in surgical care. … A systematic quantitative assessment of risks associated with poor communication in surgical care. … https://psnet.ahrq.gov/issue/systematic-quantitative-assessment-risks-associated-poor-communication- … surgical-care This study used failure mode and effect analysis to identify safety risks in perioperative … https://psnet.ahrq.gov/issue/systematic-quantitative-assessment-risks-associated-poor-communication-surgical-care

9924. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)
      www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
      December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

9925. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
      December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

9926. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)
      www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
      December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

9927. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)
      www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
      December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

9928. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)
      www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
      December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

9929. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)
      www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
      December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

9930. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)
      ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
      December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

9931. Fallpxtool4B (doc file)
      www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/fallpxtoolkit/fallpxtool4b.docx
      January 29, 2013 - Environmental risks (e.g., hooked up to IV). … Educates patient/family about fall risk factors. … Environmental risks (e.g., hooked up to IV). … CNA Reports any new fall risks to nurse. Keeps environment around bed clutter free. … Reviews medications for fall risk.

9932. Fallpxtool4B (doc file)
      ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/fallpxtoolkit/fallpxtool4b.docx
      January 29, 2013 - Environmental risks (e.g., hooked up to IV). … Educates patient/family about fall risk factors. … Environmental risks (e.g., hooked up to IV). … CNA Reports any new fall risks to nurse. Keeps environment around bed clutter free. … Reviews medications for fall risk.

9933. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
      www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
      August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

9934. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
      www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
      August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

9935. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
      www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
      August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

9936. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
      www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
      August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

9937. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
      www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
      August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

9938. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
      www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
      August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

9939. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
      ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
      August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

9940. “Near-miss” Reporting System Development and Implications for Human Subjects Protection (pdf file)
      ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Murff.pdf
      January 01, 2004 - Investigators, sponsors, and institutional review boards (IRBs) can reassess the risk-to-benefit ratio … There remains another research-related risk that is quite different from these traditional or study … risks. … to minimize these risks Study risks Clinical risks Definition Risks directly associated with use … Framework for analysing risk and safety in clinical medicine. BMJ 1988;316:1154–7. 25.